Hide Board Information

Show Board Information

CytoDyn Inc CYDY

Board Mod: HHIGambler

Asst Mods: Riztheinvestor CaptnAmerca mightycydy

Last Post: 12/25/2024 5:06:16 PM

Board Marks: 388

Posts Today: 0

Board Views Today: 1034

CytoDyn Inc. (OTCQB: CYDY)

Company Website: http://www.cytodyn.com/

CytoDyn Inc (OTCMRKTS: CYDY) Stock Message Board

1. CYDY Company Profile

    

2. CYDY Time & Sales

    

3. CYDY Recent News

    

4. CYDY Filings

    

5. CYDY Financials

    

6. CYDY Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

13623	Leronlimab (Pro 140) Cliff Notes What is it? (37)	trding	12/24/2019 8:09:27 PM
112006	Leronlimab - Disease List (currently 90) (updated (28)	ohm20	12/09/2021 8:15:12 AM
144440	Leronlimab Regulator List (a work in progress) = (18)	ohm20	06/12/2024 7:33:56 PM
145805	Here's some basics on the science - Leronlimab (44)	ohm20	08/21/2024 12:48:53 PM
71266	They may decide to do it sooner. Given (1)	ClosetInvestor	01/04/2021 7:06:37 PM
71264	Man I messed up my first post :( I meant to say	stevo180	01/04/2021 6:56:51 PM
71263	Two trading days spiking at close. Love that.	chazzledazzle	01/04/2021 6:49:07 PM
71262	Leronlimab is (we believe) effective against the (2)	CDiddy	01/04/2021 6:48:40 PM
71261	Just a general question. Is there any clinical	Joja	01/04/2021 6:42:23 PM
71260	Technical analysis... This is my first post other (2)	stevo180	01/04/2021 6:36:04 PM
71259	BUT, @ these prices...or before Covid....in the	sean007	01/04/2021 6:27:24 PM
71258	Ive seen this 30 trades above 10,000 shares	chazzledazzle	01/04/2021 6:18:31 PM
71257	To back up my statement, CYDY will be uplisting (2)	SnapShot6	01/04/2021 6:10:33 PM
71256	I could care less about their backward math.	CDiddy	01/04/2021 5:55:54 PM
71255	While, I tend to agree that we'll probably wait,	CDiddy	01/04/2021 5:55:09 PM
71254	Instituitional Investors should have CYDY are (1)	calstang	01/04/2021 5:48:38 PM
71253	Cognitive dissonance, you go BF! We all need	Longestyard	01/04/2021 5:30:36 PM
71252	"My assumption of a NASDAQ uplist is that its	SnapShot6	01/04/2021 5:25:20 PM
71251	CT, Im totally with you on saving lives. My	PersianLeo	01/04/2021 5:18:22 PM
71250	Absolutely CD12. Save lives, money will (1)	CTMedic	01/04/2021 5:10:15 PM
71249	I agree with you that SP and indications will (1)	PersianLeo	01/04/2021 4:58:46 PM
71248	Exciting times...... GLTA (2)	Shelly2626	01/04/2021 4:58:33 PM
71247	GM-CSF levels were low before treatment. The (1)	ohm20	01/04/2021 4:32:26 PM
71246	30 Trades Today of 10,000 Shares or (3)	calstang	01/04/2021 4:23:32 PM
71245	my 2cents - you want CD12 and EUA or BLA. Without (1)	jamming1092	01/04/2021 4:21:32 PM
71244	The most important thing right now is the CD12 (6)	penniestodimes	01/04/2021 4:18:48 PM
71243	What would you like to see first: CD12 Data or	PersianLeo	01/04/2021 4:09:29 PM
71242	Closing 10% high with less than average volume on (7)	PersianLeo	01/04/2021 4:06:59 PM
71241	Get in NOW or regret tmrws	WinstonNC	01/04/2021 3:58:51 PM
71240	Closing Strong odds on Gapper tmrw... Agree	COInvestor	01/04/2021 3:57:18 PM
71239	Closing Strong odds on Gapper (1)	WinstonNC	01/04/2021 3:53:14 PM
71238	Does that sound like sequencing? GM-CSF goes up (1)	Borel Fields	01/04/2021 3:50:06 PM
71236	JL...you are right on .... Hilarious.... ... (1)	Shelly2626	01/04/2021 3:37:39 PM
71235	Good point.	Riztheinvestor	01/04/2021 3:35:30 PM
71234	You are correct that I was taking their	Borel Fields	01/04/2021 3:34:54 PM
71233	ANY investor worth his salt would connect the (1)	sean007	01/04/2021 3:21:22 PM
71232	I'm not aware of any results from	CDiddy	01/04/2021 3:21:15 PM
71230	Thanks for the clarification Doctor....It has	sean007	01/04/2021 3:06:31 PM
71229	Just announced, UK on a new, nationwide lockdown. (1)	Boatbuilder	01/04/2021 3:06:29 PM
71228	drug trials during covid this should 100% apply (1)	swordman	01/04/2021 3:04:49 PM
71227	One thing that's interesting is that as (4)	ohm20	01/04/2021 2:59:48 PM
71226	Ive looked at lenzilumab much more closely. I	Riztheinvestor	01/04/2021 2:51:19 PM
71224	New WSJ story on long haulers (2)	Dr Zaius	01/04/2021 2:48:11 PM
71221	Somewhat (stock twits)... I think the larger (8)	JLang	01/04/2021 2:45:13 PM
71220	Here is a recent publication on cytokine storms (4)	mtruong34	01/04/2021 2:31:37 PM
71219	Jlang, Agreed, but why the recognition and	CTMedic	01/04/2021 2:31:00 PM
71218	Help, please, re: leron/lenzi comparison I think (1)	Borel Fields	01/04/2021 2:20:06 PM
71217	That drug would have the same effect on mTORc1 as (5)	ohm20	01/04/2021 2:12:29 PM
71216	https://www.ndtv.com/world-news/vaccines-may-not- (1)	onestepahead	01/04/2021 2:06:29 PM
71214	ohms message on stocktwits 09:15 AM @Darronm (1)	dfwl28	01/04/2021 1:26:19 PM
71213	The main reason for the reminder was to include (2)	mtruong34	01/04/2021 1:22:32 PM
71212	What are we supposed to do? Buy more? I, for one, (3)	Evil Rabbit	01/04/2021 1:17:24 PM
71211	Lenzulimab has effect. With their exclusion (1)	ohm20	01/04/2021 1:11:36 PM
71210	Their investors heard about leronlimab. (5)	ohm20	01/04/2021 1:05:10 PM

Newer

Older

Recent Articles

• Discover the Power and Luxury of the 2025 Toyota Tundra
• Experience the Journey with BC.GAME's New Wukong Slot Game
• Enhance Your Vehicle's Performance with Expert Tune-Ups
• EHang Launches National Headquarters for Emergency Rescues
• Himax Showcases Leading Automotive Display Innovations at CES
• Himax Unveils Next-Gen Automotive Display Solutions at CES
• Major Hydropower Initiative on the Tibetan Plateau Unveiled
• Mentech Partners with Team Visma | Lease a Bike for Growth
• Geek Bar Excels at Vaping360 Annual Awards in Germany
• Unlocking Growth: China's New Law to Empower Private Sector
• Mentech Partners with Visma | Lease a Bike to Boost Cycling Tech
• Jeff Wong Joins WSPN as Independent Director to Drive Innovation
• Innovative Solutions from Green Tech Accelerator for Sustainability
• Innovative Ways Green Tech Accelerator Aims to Change Sustainability
• Iran's Government Eases Internet Restrictions with New Moves
• Asian Stock Markets Experience Mixed Reactions Amid Holidays
• Matwings Technology Secures Major Funding for Protein Innovation
• Sinopec's New Petrochemical Base Sets Global Standards
• Dentsply Sirona: Investors Urged to Act in Legal Matters
• China's Stimulus Measures Push Oil Prices Higher
• Dollar Strengthens While Asian Markets Celebrate Gains
• Japan Airlines Cyberattack Disruption Affects Flight Operations
• Key Insights into US Economic Resilience for 2025
• Elon Musk Applauds McDonald's Evangelion Collaboration
• Exploring Haikou: A Harmonious Blend of Tradition and Innovation
• Market Boosted by Hopes for China's Economic Support Measures
• Axcelead DDP Partners with Astellas to Advance Drug Discovery
• Strengthening Partnerships: OKI and FPT Collaborate Globally
• Denmark Increases Greenland's Defense Spending Amid Political Tensions
• Japan Anticipates Positive Economic Shift After Seven Years
• Tragic Incident: Unidentified Body Discovered on United Flight
• SP Manufacturing Bolsters Growth with New Factory and Acquisition
• U.S. Stock Futures Steady Amid Holiday Market Trends
• Investors Eye Class Action Against Sun Communities, Inc. SUI
• Short Interest on NYSE Sees Notable Increase in December
• Mark Cuban's Insight: Home Insurance Outweighs Interest Rates
• Investors Can Seize Opportunity in Symbotic Class Action Lawsuit
• Opportunity for WBD Investors: Join the Class Action Now
• Transforming Surgical Documentation with Casect's AI Technology
• Moscow Stocks Rise with Key Indices Reaching New Heights
• Canadian Market Highlights: S&P/TSX Composite Expands Gains
• Colombia Stock Market Overview: Key Players and Trends
• Mexican Markets Tumble as Economic Indicators Shift
• Customers Bancorp Investors Urged to Act Before Lead Deadline
• Opportunities for ASP Isotopes Investors Amid Legal Actions
• MGP Ingredients Faces Class Action Lawsuit: Investors Alert
• Legal Action Alert: Humacyte, Inc. Faces Class Action Lawsuit
• Kaspi.kz Investors Can Join Class Action for Compensation
• Understanding the Class Action Against Five9, Inc. (FIVN)
• Wolfspeed, Inc. Investors Prepare for Class Action Lawsuit